2026 NPPES data Allergy & Immunology Physician NPI 1578538476 M.D.
Verify on CMS →

AMI DEGALA, M.D.

Allergy & Immunology Physician in PALM HARBOR, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
384
Medicare Part D claims · 95 beneficiaries · Allergy & Immunology Physician avg: 764
Generic prescribing
66%
generic claims · 34% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.1K
39 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: AMI DEGALA, M.D. is a Allergy & Immunology Physician ([object Object]) practicing in PALM HARBOR, Florida with a Medicare Part D prescribing footprint of 384 claims across 95 beneficiaries — 34% brand-name prescribing . Industry payments of $1.1K across 39 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: AMI DEGALA, M.D. filed 384 Medicare Part D claims in 2023 across PALM HARBOR, Florida. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

AMI DEGALA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

AMI DEGALA, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 02/22/2006

NPI 1578538476

Primary specialty

Allergy & Immunology Physician

Niche

3,390 US NPIs in this specialty

Medicare Part D claims

384 50% vs specialty avg

2023 prescription claims

Specialty avg: 764

Specialty distribution in Florida

How Allergy & Immunology Physician compares to other specialties among Florida providers

Florida providers

Allergy & Immunology Physician share within Florida

1. Allergy & Immunology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Allergy & Immunology Physician share within Florida

Specialty board-certification context

Estimated specialty board-certified rate — Allergy & Immunology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Allergy & Immunology Physician ABMS/AOA estimate

Est. board-certified rate (Allergy & Immunology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Allergy & Immunology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

AMI DEGALA, M.D. is a Allergy & Immunology Physician provider practicing in PALM HARBOR, Florida, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1578538476. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

AMI DEGALA, M.D. appears in the CMS NPPES registry as a Allergy & Immunology Physician provider holding M.D. credentials at 33920 US HIGHWAY 19N SUITE 341, PALM HARBOR, FL, 34684, with a listed phone of (727) 787-6744. NPI 1578538476 was issued on 02/22/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DEGALA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 384 prescription claims written by this provider, covering 95 Medicare beneficiaries and totaling roughly $96K in drug spend, split 34% brand-name and 66% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Allergy & Immunology Physician is a narrow specialty nationwide, with 3,390 enrolled providers across 52 states and an average of 764 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

33920 US HIGHWAY 19N SUITE 341
PALM HARBOR, FL 34684

Provider Details

NPI 1578538476
Specialty Allergy & Immunology Physician
Credentials M.D.
Gender Female
NPI Issued 02/22/2006

Hospital and facility affiliations

Facilities where AMI DEGALA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

DENNIS H KIM MD LLC
PALM HARBOR, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for AMI DEGALA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.1K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to AMI DEGALA, M.D.. To verify AMI DEGALA, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

AMI DEGALA, M.D. — brand share 34.0%
Specialty average (est.)

34% brand-name claims vs 66% generic, on 384 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

384
Total Claims
$96K
Total Drug Cost
95
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
567
Total Day Supply
14,881
Brand vs Generic
34% brand / 66% generic
Brand Drug Cost
$87K
Generic Drug Cost
$9K
Antibiotic Claims
18

Patient Demographics

Average Patient Age
70.8 years
Avg HCC Risk Score
1.25
Gender Split
68% female / 32% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Albuterol Sulfate Hfa
Albuterol Sulfate
43
Fluticasone Propionate
31
Prednisone
30
Levocetirizine Dihydrochloride
27
Montelukast Sodium
25
Ipratropium Bromide
24
Epinephrine
23
Symbicort
Budesonide/Formoterol Fumarate
21
Famotidine
20
Azelastine Hcl
17

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Allergy & Immunology Physician Overview

How AMI DEGALA, M.D. fits within the Allergy & Immunology Physician landscape nationally.

3,390
Allergy & Immunology Physician Providers in US
52
States with Allergy & Immunology Physician
764
Avg Claims per Provider

AMI DEGALA, M.D.'s 384 claims are below the specialty average of 764.

Nearby Allergy & Immunology Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as DEGALA.

Compare Allergy & Immunology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is AMI DEGALA, M.D.'s specialty?
AMI DEGALA, M.D. specializes in Allergy & Immunology Physician and practices in PALM HARBOR, Florida. Credentials: M.D..
How much does AMI DEGALA, M.D. prescribe under Medicare Part D?
In 2023, AMI DEGALA, M.D. wrote 384 Medicare Part D claims totaling $96K in drug costs for 95 beneficiaries.
Where is AMI DEGALA, M.D. located?
AMI DEGALA, M.D. is located at 33920 US HIGHWAY 19N SUITE 341, PALM HARBOR, FL, 34684. Phone: (727) 787-6744.
What is AMI DEGALA, M.D.'s NPI number?
AMI DEGALA, M.D.'s National Provider Identifier (NPI) is 1578538476, issued on 02/22/2006.
Does AMI DEGALA, M.D. prescribe more brand-name or generic drugs?
AMI DEGALA, M.D.'s prescribing is 34% brand-name and 66% generic drugs by claim count, with $87K in brand drug costs.
How many Allergy & Immunology Physician providers are there in the US?
There are 3,390 Allergy & Immunology Physician providers across 52 states in the US. The average Allergy & Immunology Physician provider writes 764 Medicare Part D claims per year.
What drugs does AMI DEGALA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, AMI DEGALA, M.D.'s most frequently prescribed drugs include Albuterol Sulfate Hfa, Fluticasone Propionate, Prednisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does AMI DEGALA, M.D. accept Medicare?
AMI DEGALA, M.D. appears in CMS Medicare data with 384 Part D claims and 95 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify AMI DEGALA, M.D.'s credentials?
AMI DEGALA, M.D.'s NPI is 1578538476 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology